Ragupathy Madiyalakan
Chief Executive Officer at QUEST PHARMATECH INC.
Net worth: 48 000 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| J. Lievonen | M | - | 7 years | |
| Jae-Jin Park | M | 62 | - | |
| William Meekison | M | 58 |
OncoQuest, Inc.
 OncoQuest, Inc. BiotechnologyHealth Technology OncoQuest, Inc. is a Canadian biotechnology company, which engages in developing and commercializing products for the treatment of cancer. The company is headquartered in Edmonton, Canada. | 5 years |
| Bin Huang | M | 65 |
OncoQuest, Inc.
OncoQuest, Inc. BiotechnologyHealth Technology OncoQuest, Inc. is a Canadian biotechnology company, which engages in developing and commercializing products for the treatment of cancer. The company is headquartered in Edmonton, Canada. | 9 years |
| Shawn Lu | M | 56 |
OncoQuest, Inc.
OncoQuest, Inc. BiotechnologyHealth Technology OncoQuest, Inc. is a Canadian biotechnology company, which engages in developing and commercializing products for the treatment of cancer. The company is headquartered in Edmonton, Canada. | 9 years |
| Karthik Radhakrishnan | M | - |
Oncoquest Pharma USA, Inc.
 Oncoquest Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Oncoquest Pharma USA, Inc. manufactures pharmaceutical products. The private company is based in Miryang-si, South Korea. | - |
| Pierre Vermette | M | - | 19 years | |
| Cheol-Geun Yoo | M | 67 | 5 years | |
| Jeong-Gun Im | F | 42 |
Oncoquest Pharma USA, Inc.
Oncoquest Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Oncoquest Pharma USA, Inc. manufactures pharmaceutical products. The private company is based in Miryang-si, South Korea. | - |
| Tae-Woong Byun | M | 54 | - | |
| Sung-Jin Jeong | M | 43 |
Oncoquest Pharma USA, Inc.
Oncoquest Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Oncoquest Pharma USA, Inc. manufactures pharmaceutical products. The private company is based in Miryang-si, South Korea. | - |
| Ryong Sung | M | 59 | - | |
| Jong-Seok Woo | M | - | 5 years | |
| Kwang-Chul Ko | M | - | - | |
| Jeffrey Shon | M | - | 3 years | |
| Chang-Hyun Lee | M | 45 | 5 years | |
| Alex Jung | M | - |
Oncoquest Pharma USA, Inc.
Oncoquest Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Oncoquest Pharma USA, Inc. manufactures pharmaceutical products. The private company is based in Miryang-si, South Korea. | - |
| Lyn Lim | M | - |
Oncoquest Pharma USA, Inc.
Oncoquest Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Oncoquest Pharma USA, Inc. manufactures pharmaceutical products. The private company is based in Miryang-si, South Korea. | - |
| Sunil Gupta | M | - | 4 years | |
| Eliel Bayever | M | - | - | |
| Stanley Kim | M | - |
OncoQuest, Inc.
OncoQuest, Inc. BiotechnologyHealth Technology OncoQuest, Inc. is a Canadian biotechnology company, which engages in developing and commercializing products for the treatment of cancer. The company is headquartered in Edmonton, Canada. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lorne T. Meikle | M | - | 11 years | |
| Don B. Rix | M | 93 | - | |
| T. Alex McPherson | M | 85 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 15 years |
| Paul van Damme | M | - | 5 years | |
| Ian McConnan | M | - | 13 years | |
| Eric Shi | M | 63 | - | |
| Michael C. Welsh | M | 81 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 20 years |
| David J. Cox | M | - | 1 years | |
| Robert D. Aubrey | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 17 years |
| Marilyn Olson | F | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 18 years |
| Thomas Woo | M | - | - | |
| Garth Likes | M | 70 | - | |
| Mark Krantz | M | - |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 15 years |
| Mark Reddish | M | 69 |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 7 years |
| Norma Beauchamp | F | 62 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 23 | 63.89% |
| South Korea | 14 | 38.89% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ragupathy Madiyalakan
- Personal Network
